Market Overview:
The global ribavirin API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hepatitis C, rising demand for novel therapies, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global ribavirin API market is segmented into purity 98% and purity 99%. The purity 98% segment is expected to account for a larger share of the market than the purity 99% segment during the forecast period. This can be attributed to its lower cost and easy availability as compared with other types of ribavirin APIs. Based on application, the global ribavirin API market is divided into tablets and capsules. The tablets segment is anticipated to hold a larger share of this market than capsules during 2018-2030 owing to their higher demand from patients across regions.
Product Definition:
Ribavirin API is an antiviral drug used to treat severe respiratory syncytial virus (RSV) infections in infants and children. It may also be used to prevent RSV infection in people who are at high risk for the illness. Ribavirin API is important because it can help reduce serious respiratory problems in infants and children.
Purity 98%:
Purity 98% is a crystalline form of the drug, which is manufactured by the removal of two molecules of water from ribavirin. It has an amorphous solid state and is white in color. Purity 98% contains no additives or fillers and has not been reformulated to increase its potency. The product was developed as an alternative for patients who cannot afford expensive branded drugs, but have a need for highly effective medication with reduced adverse effects at a low cost.
Purity 99%:
Purity 99% is a crystalline powder made from the purest form of ribavirin. It has no other additives and is used as an intermediate in manufacturing various medicines such as antiviral, antiretroviral, and anti-retroviral drugs. Purity 99% is also known to have high purity with excellent quality which can be used for research purposes by pharmaceutical companies or even for drug development by biotech firms.
Application Insights:
Ribavirin tablets were the most prominent application segment in the global market and accounted for a revenue share of over 60% in 2017. The product is used to treat patients with hepatitis C infection who are experiencing nausea, fatigue, abdominal pain and loss of appetite. Ribavirin capsules are also used to prevent hepatitis C infection among high-risk populations including intravenous drug users, transplant recipients and people with multiple sexual partners or chronic liver disease.
The demand for ribavirin API from capsule form is expected to witness growth owing to its usage as an antiviral agent against HCV genotype 1 & 4 infections that exhibit resistance towards interferon therapy or non-toxicology drugs such as boceprevir/ telbivir. In addition, increasing awareness about the benefits associated with ribavirin capsules coupled with growing adoption across emerging economies such as China and India will further propel industry expansion over the forecast period.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The presence of a large number of manufacturers coupled with high R&D expenditure and technological advancements are some factors attributing to its largest share. In addition, increasing demand for novel therapeutics is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to untapped opportunities and rapidly growing economies such as China, India, Indonesia & Malaysia among others.
Growth Factors:
- Increasing incidence of chronic hepatitis C infections: The major growth driver for the Ribavirin API market is the increasing incidence of chronic hepatitis C infections across the globe. According to World Health Organization (WHO), around 71 million people are chronically infected with hepatitis C virus (HCV) worldwide, and 350,000 people die due to HCV-related diseases every year. This is mainly because there is no vaccine available for HCV and current therapies are expensive and have several side effects. Hence, there is a huge unmet need for better and more affordable therapies for HCV infection, which is expected to drive the demand for Ribavirin APIs in coming years.
- Rising prevalence of HIV/AIDS: Another key growth driver for Ribavirin API market is the rising prevalence of HIV/AIDS across the globe. As per WHO estimates, around 36 million people were living with HIV/AIDS as on 2016, out of which 1.8 million were children below 15 years of age. This high prevalence has led to an increase in demand for antiretroviral drugs over past few years, driving the growth of Ribavirin API market as well..
- . This will
Scope Of The Report
Report Attributes
Report Details
Report Title
Ribavirin API Market Research Report
By Type
Purity 98%, Purity 99%
By Application
Ribavirin Tablets, Ribavirin Capsule
By Companies
Amri, Euticals Group, Aurobindo Pharma, Bidachem, Chengdu Brilliant Pharmaceutical, Mayo Clinic, Nortec Quimica, Siegfried, Trimax Bio Sciences, Yamasa Corporation, Tuoxin Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Ribavirin API Market Report Segments:
The global Ribavirin API market is segmented on the basis of:
Types
Purity 98%, Purity 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ribavirin Tablets, Ribavirin Capsule
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amri
- Euticals Group
- Aurobindo Pharma
- Bidachem
- Chengdu Brilliant Pharmaceutical
- Mayo Clinic
- Nortec Quimica
- Siegfried
- Trimax Bio Sciences
- Yamasa Corporation
- Tuoxin Pharma
Highlights of The Ribavirin API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 98%
- Purity 99%
- By Application:
- Ribavirin Tablets
- Ribavirin Capsule
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ribavirin API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ribavirin API is a medication used to treat hepatitis C. It works by stopping the virus from multiplying in your body. Ribavirin API is usually taken with other medications to help cure hepatitis C.
Some of the major players in the ribavirin api market are Amri, Euticals Group, Aurobindo Pharma, Bidachem, Chengdu Brilliant Pharmaceutical, Mayo Clinic, Nortec Quimica, Siegfried, Trimax Bio Sciences, Yamasa Corporation, Tuoxin Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ribavirin API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ribavirin API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ribavirin API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ribavirin API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ribavirin API Market Size & Forecast, 2020-2028
4.5.1 Ribavirin API Market Size and Y-o-Y Growth
4.5.2 Ribavirin API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity 98%
5.2.2 Purity 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Ribavirin Tablets
6.2.2 Ribavirin Capsule
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ribavirin API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ribavirin API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity 98%
9.6.2 Purity 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Ribavirin Tablets
9.10.2 Ribavirin Capsule
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity 98%
10.6.2 Purity 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Ribavirin Tablets
10.10.2 Ribavirin Capsule
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity 98%
11.6.2 Purity 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Ribavirin Tablets
11.10.2 Ribavirin Capsule
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity 98%
12.6.2 Purity 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Ribavirin Tablets
12.10.2 Ribavirin Capsule
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity 98%
13.6.2 Purity 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Ribavirin Tablets
13.10.2 Ribavirin Capsule
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ribavirin API Market: Competitive Dashboard
14.2 Global Ribavirin API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amri
14.3.2 Euticals Group
14.3.3 Aurobindo Pharma
14.3.4 Bidachem
14.3.5 Chengdu Brilliant Pharmaceutical
14.3.6 Mayo Clinic
14.3.7 Nortec Quimica
14.3.8 Siegfried
14.3.9 Trimax Bio Sciences
14.3.10 Yamasa Corporation
14.3.11 Tuoxin Pharma
